Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset-Reference-Cited by-同舟云学术

Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset

Published:2024-04 Issue:4 Volume:9 Page:102996
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Germani M.M.^ORCID,Vetere G.^ORCID,Santamaria F.^ORCID,Intini R.,Ghelardi F.,Bensi M.^ORCID,Boccaccino A.^ORCID,Minelli A.,Carullo M.^ORCID,Ciracì P.^ORCID,Passardi A.^ORCID,Santucci S.,Giampieri R.^ORCID,Persano M.,Fenocchio E.,Puccini A.^ORCID,Lonardi S.^ORCID,Pietrantonio F.^ORCID,Salvatore L.^ORCID,Cremolini C.

Publisher

Elsevier BV

Reference29 articles.

1. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies;Clarke;J Gastrointest Oncol,2015

2. BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection;Schirripa;Br J Cancer,2015

3. BRAF V600E mutation in first-line metastatic colorectal cancer: an analysis of individual patient data from the ARCAD database;Cohen;J Natl Cancer Inst,2021

4. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer;André;N Engl J Med,2020

5. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study;Diaz;Lancet Oncol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study;ESMO Open;2024-09

2. Genetic Association between Primary Colorectal Cancer and Melanoma Skin Cancer: A Bidirectional Two-Sample Mendelian Randomization Analysis;2024